Market revenue in 2023 | USD 21.4 million |
Market revenue in 2030 | USD 41.4 million |
Growth rate | 9.9% (CAGR from 2023 to 2030) |
Largest segment | Outsourcing |
Fastest growing segment | Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In-House, Outsourcing |
Key market players worldwide | Steris PLC, Sotera Health Co Ordinary Shares, Sartorius AG, Solvias, SGS AG, Labcorp Holdings Inc, Pace Analytical Services, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Rapid Micro Biosystems Inc Class A, Almac Group, Pacific BioLabs, Inc., Boston Analytical, Labor LS |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical sterility testing market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 58.88% in 2023. Horizon Databook has segmented the Belgium pharmaceutical sterility testing market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
The expansion of the pharmaceutical and biotechnology industries in Belgium is boosting the demand for pharmaceutical sterility testing to maintain high-quality standards in drug manufacturing.
According to the International Trade Administration, Belgium is the fourth-largest global exporter of pharmaceutical products, following Germany, Switzerland, and the U.S.
It serves as a significant hub for pharmaceutical transportation & manufacturing and represents a pivotal market for Multinational entities seeking opportunities in R&D, biotechnology, and clinical trials. The country holds a significant global position across the entire biopharmaceutical value chain, encompassing R&D, clinical trials, production, logistics, and international trade.
Horizon Databook provides a detailed overview of country-level data and insights on the Belgium pharmaceutical sterility testing market , including forecasts for subscribers. This country databook contains high-level insights into Belgium pharmaceutical sterility testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account